同步18F-FDG PET/MRI联合代谢体积参数与表观扩散系数在接受治疗的头颈癌中的预后价值
本研究回顾性纳入72例头颈癌术后患者,评估同步18F-FDG PET/MRI参数对治疗失败的预测价值。单因素分析中MTV(P=0.044)、MTV/ADCmean(P=0.022)、TLG/ADCmean(P=0.044)、淋巴管侵犯(P=0.044)和神经周围侵犯(P=0.046)显著。多因素分析中MTV(P=0.026)、MTV/ADCmean(P=0.011)、TLG/ADCmean(P=0.002)及淋巴管侵犯显著。结论认为联合PET/MRI参数可能是术后治疗失败的有效预测因子。
要点
- 72例头颈癌术后患者中22例(30.6%)出现治疗失败,平均失败时间13.0±7.0个月。
- 多因素分析显示MTV(P=0.026)、MTV/ADCmean(P=0.011)、TLG/ADCmean(P=0.002)与治疗失败显著相关。
- 联合PET/MRI参数(代谢体积参数经肿瘤细胞密度校正)可能是术后治疗失败的有效预测因子。
核心结论
- 联合PET/MRI参数(经肿瘤细胞密度校正的PET代谢体积参数)除MTV和临床病理参数外,可能是头颈癌术后肿瘤治疗失败的有效预测因子。
研究设计与样本
- 回顾性纳入72例(平均年龄55.9±14.6岁,男45例、女27例)在头颈癌手术前接受同步18F-FDG PET/MRI的患者。
主要发现
- 22例(30.6%)在头颈癌术后出现肿瘤治疗失败,平均治疗失败时间13.0±7.0个月。
- 单因素分析中,18F-FDG PET/MRI参数中MTV(P=0.044)、MTV/ADCmean(P=0.022)、TLG/ADCmean(P=0.044)显著;临床病理参数中淋巴管侵犯(P=0.044)和神经周围侵犯(P=0.046)显著。
- 多因素分析中,MTV(P=0.026)、MTV/ADCmean(P=0.011)、TLG/ADCmean(P=0.002)及淋巴管侵犯(P分别为0.026、0.026、0.044)显著。
关键数值与推荐
- SUVmax作为代谢参数测量;MTV和TLG作为代谢体积参数检查;ADCmean在ADC图上评估作为MRI参数。
- 代谢/代谢体积参数与ADC的比值计算为联合PET/MRI参数。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to determine the usefulness of combined positron emission tomography (PET)/magnetic resonance imaging (MRI) parameters provided by simultaneous 18F-fluorodeoxyglucose (FDG) PET/MRI for the prediction of treatment failure in surgically resected head and neck cancer. We hypothesized that PET parameters corrected by tumor cellularity (combined PET/MRI parameters) could predict the prognosis. On regional PET, maximum standardized uptake value (SUVmax) was measured as metabolic parameters. In addition, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were checked as metabolo-volumetric parameters. Mean apparent diffusion coefficient (ADCmean) of tumor was evaluated as the MRI parameter on the ADC map. Ratios between metabolic/metabolo-volumetric parameters and ADC were calculated as combined PET/MRI parameters. PET, MRI, and combined PET/MRI parameters were compared with clinicopathologic parameters in terms of treatment failure. RESULTS: Seventy-two patients (mean age = 55.9 ± 14.6 year, M: F = 45: 27) who underwent simultaneous 18F-FDG PET/MRI before head and neck cancer surgery were retrospectively enrolled. Twenty-two patients (30.6%) showed tumor treatment failure after head and neck cancer surgery (mean treatment failure = 13.0 ± 7.0 months). In the univariate analysis, MTV (P = 0.044) and ratios between metabolo-volumetric parameters and ADC (MTV/ADCmean, P = 0.022; TLG/ADCmean, P = 0.044) demonstrated significance among 18F-FDG PET/MRI parameters. Lymphatic invasion (P = 0.044) and perineural invasion (P = 0.046) revealed significance among clinicopathologic parameters. In the multivariate analysis, MTV (P = 0.026), MTV/ADCmean (P = 0.011), and TLG/ADCmean (P = 0.002) with lymphatic invasion (P = 0.026, 0.026, and 0.044, respectively) showed significance. CONCLUSIONS: Combined PET/MRI parameters (PET metabolo-volumetric parameters corrected by tumor cellularity) could be effective predictors of tumor treatment failure after head and neck cancer surgery in addition to MTV and clinicopathologic parameter.
引用
- Kim YI, Cheon GJ, Kang SY, et al. Prognostic value of simultaneous 18F-FDG PET/MRI using a combination of metabolo-volumetric parameters and apparent diffusion coefficient in treated head and neck cancer. EJNMMI Res. 2018. PMID: 29322269. doi:10.1186/s13550-018-0357-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。